| 2007-Q1 (n = 406) | 2016-Q4 (n = 336) |
---|---|---|
If not stated otherwise mean proportion (standard deviation) | ||
Composition | ||
 Therapists | 0.45 (0.11) | 0.47 (0.07) |
 General practitioners | 0.13 (0.06) | 0.12 (0.03) |
 Other disciplines | 0.13 (0.05) | 0.12 (0.04) |
 Multidisciplinary practices | 0.08 (0.04) | 0.08 (0.04) |
 Psychologists and psychotherapists | 0.07 (0.03) | 0.06 (0.03) |
 Internists | 0.06 (0.02) | 0.06 (0.02) |
 Ophthalmologists | 0.02 (0.01) | 0.02 (0.01) |
 Surgeons | 0.02 (0.01) | 0.02 (0.01) |
 Orthopaedics | 0.02 (0.01) | 0.02 (0.01) |
 Urologists | 0.01 (0.01) | 0.01 (0.00) |
 Rehabilitation facilities | 0.01 (0.01) | 0.01 (0.01) |
 Hospitals | 0.01 (0.01) | 0.01 (0.00) |
 Proportion of care-dependent people in provider network (cluster) | 0.09 (0.06) | 0.14 (0.04) |
 Number of providers in cluster (Mean, SD) | 825.05 (982.07) | 918.60 (1044.78) |
 Number of patients in cluster (PN-dataset) (Mean, SD) | 16,334.37 (17,981.95) | 16,636.75 (18,631.82) |
 Number of patients in cluster (cohort dataset) (Mean, SD) | 288.36 (358.91) | 26.67 (37.52) |
 Number of comorbidities (Mean, SD) | 1.83 (0.18) | 2.29 (0.19) |
Quality of care indicators | ||
 COC Asthma (Mean, SD) | 0.78 (0.05) | 0.60 (0.10) |
 SECON Asthma (Mean, SD) | 0.88 (0.03) | 0.82 (0.07) |
 UPC Asthma (Mean, SD) | 0.86 (0.04) | 0.76 (0.06) |
 COC COPD (Mean, SD) | 0.79 (0.04) | 0.70 (0.06) |
 SECON COPD (Mean, SD) | 0.89 (0.03) | 0.79 (0.04) |
 UPC COPD (Mean, SD) | 0.87 (0.03) | 0.81 (0.04) |
 COC Dementia (Mean, SD) | 0.85 (0.04) | 0.78 (0.05) |
 SECON Dementia (Mean, SD) | 0.93 (0.02) | 0.85 (0.03) |
 UPC Dementia (Mean, SD) | 0.91 (0.03) | 0.86 (0.03) |
 COC Diabetes (Mean, SD) | 0.82 (0.04) | 0.73 (0.07) |
 SECON Diabetes (Mean, SD) | 0.92 (0.02) | 0.80 (0.06) |
 UPC Diabetes (Mean, SD) | 0.88 (0.03) | 0.82 (0.05) |
 COC Heart Failure (Mean, SD) | 0.78 (0.05) | 0.68 (0.06) |
 SECON Heart Failure (Mean, SD) | 0.90 (0.03) | 0.80 (0.04) |
 UPC Heart Failure (Mean, SD) | 0.86 (0.04) | 0.80 (0.05) |
 Asthma: Prevalence | 0.04 (0.01) | 0.06 (0.02) |
 Asthma: Spirometry | 0.33 (0.14) | 0.40 (0.17) |
 Asthma: Inhalative medication | 0.46 (0.10) | 0.47 (0.08) |
 Asthma: ICS | 0.28 (0.09) | 0.25 (0.08) |
 Medication: PRISCUS | 0.20 (0.03) | 0.15 (0.02) |
 Medication: Beta-Blocker after myocardial infarction | 0.55 (0.06) | 0.65 (0.04) |
 Medication: ACE-inhibitor upon hypertension and renal insufficiency | 0.45 (0.06) | 0.38 (0.04) |
 Medication: ACE-inhibitor upon heart failure | 0.47 (0.07) | 0.39 (0.04) |
 Medication: Beta-blocker upon asthma | 0.20 (0.06) | 0.31 (0.05) |
 Medication: Electrolyte check upon diuretics | 0.24 (0.06) | 0.27 (0.07) |
 Medication: Polypharmacy | 0.32 (0.04) | 0.40 (0.04) |
 Ambulatory care sensitive hospital cases | 0.03 (0.01) | 0.03 (0.01) |
 COPD: Prevalence | 0.09 (0.02) | 0.13 (0.03) |
 COPD: Inhalative medication | 0.43 (0.05) | 0.47 (0.04) |
 COPD: Acute inpatient treatment | 0.03 (0.01) | 0.02 (0.01) |
 COPD: Respiratory therapy | 0.04 (0.03) | 0.08 (0.03) |
 COPD: Influenza vaccination | 0.01 (0.01) | 0.30 (0.08) |
 COPD: Specific beta-blocker therapy | 0.34 (0.05) | 0.43 (0.05) |
 COPD: Specific anticholinergic therapy | 0.20 (0.04) | 0.27 (0.04) |
 COPD: Oral corticosteroids | 0.12 (0.04) | 0.10 (0.02) |
 CVD: Prevalence hypertension | 0.61 (0.06) | 0.72 (0.05) |
 CVD: Medication for hypertension | 0.05 (0.02) | 0.05 (0.02) |
 CVD: Prevalence heart failure | 0.02 (0.01) | 0.06 (0.03) |
 CVD: Echocardiography upon heart failure | 0.05 (0.14) | 0.08 (0.19) |
 CVD: 12-lead ECG upon heart failure | 0.10 (0.18) | 0.11 (0.22) |
 CVD: ACE-inhibiter upon heart failure | 0.57 (0.08) | 0.62 (0.04) |
 CVD: Beta-blocker upon heart failure | 0.48 (0.08) | 0.58 (0.05) |
 CVD: Anticoagulant upon atrial fibrillation and heart failure | 0.41 (0.10) | 0.32 (0.10) |
 CVD: Referral to cardiologist upon heart failure | 0.01 (0.06) | 0.27 (0.32) |
 CVD: Acute inpatient treatment of heart failure | 0.14 (0.06) | 0.06 (0.03) |
 CVD: Apoplexy treatment in stroke unit | 0.02 (0.01) | 0.03 (0.02) |
 CVD: Platelet aggregation inhibitor upon stable chronic coronary heart disease | 0.21 (0.05) | 0.27 (0.05) |
 CVD: Statins upon coronary heart disease | 0.29 (0.05) | 0.46 (0.05) |
 CVD: Anti-hypertensive therapy upon coronary heart disease and hypertension | 0.85 (0.02) | 0.89 (0.02) |
 Dementia: Prevalence | 0.04 (0.02) | 0.07 (0.02) |
 Dementia: B12 and TSH | 0.01 (0.02) | 0.04 (0.04) |
 T2D: Prevalence | 0.22 (0.05) | 0.30 (0.05) |
 T2D: HbA1c | 0.61 (0.08) | 0.61 (0.15) |
 T2D: Ophthalmological examination | 0.26 (0.08) | 0.28 (0.04) |
 T2D: Fundus examination | 0.16 (0.04) | 0.14 (0.04) |
 T2D: Triglycerides and cholesterol | 0.19 (0.09) | 0.20 (0.09) |
 T2D: Hypertension, nephropathy and ACE-inhibitor or AT1-blocker | 0.62 (0.10) | 0.67 (0.04) |
 T2D: Serum-creatinine | 0.57 (0.08) | 0.56 (0.12) |
 Osteoarthritis: Prevalence | 0.26 (0.04) | 0.35 (0.05) |
 Osteoporosis: Prevalence | 0.10 (0.02) | 0.12 (0.02) |
 Prevention: Influenza vaccination | 0.01 (0.01) | 0.25 (0.08) |
 Prevention: Mammography | 0.01 (0.03) | 0.03 (0.04) |
 Prevention: Faecal occult blood test | 0.02 (0.01) | 0.01 (0.00) |
 Prevention: Men's cancer screening | 0.07 (0.02) | 0.07 (0.02) |
 Prevention: Skin-cancer screening | 0.00 (0.00) | 0.01 (0.00) |
 Depression: Prevalence | 0.12 (0.03) | 0.18 (0.03) |
 Depression: Anti-depressive pharmacotherapy | 0.35 (0.05) | 0.34 (0.04) |